1. Choi, Jung-A, Kwon, Hyunja, Cho, Hanbyoul, Hewitt, Stephen M, Kim, Jae-Hoon. 2019. ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer. In Cancers, 11, . doi:10.3390/cancers11101553. https://pubmed.ncbi.nlm.nih.gov/31615043/
2. Rankin, Scott A, Steimle, Jeffrey D, Yang, Xinan H, Moskowitz, Ivan P, Zorn, Aaron M. 2021. Tbx5 drives Aldh1a2 expression to regulate a RA-Hedgehog-Wnt gene regulatory network coordinating cardiopulmonary development. In eLife, 10, . doi:10.7554/eLife.69288. https://pubmed.ncbi.nlm.nih.gov/34643182/
3. Liu, Wen-Bin, Fermin, Damian, Xu, An-Long, Kopp, Jeffrey B, Xu, Qihe. 2024. Single-cell RNA sequencing data locate ALDH1A2-mediated retinoic acid synthetic pathway to glomerular parietal epithelial cells. In Experimental biology and medicine (Maywood, N.J.), 249, 10167. doi:10.3389/ebm.2024.10167. https://pubmed.ncbi.nlm.nih.gov/39360029/
4. Zhang, Di, Li, Qiang, Zhang, Dandan, Li, Zhaofang, Xiong, Yongmin. 2022. An eQTL variant of ALDH1A2 is associated with Kashin-Beck disease in Chinese population. In Journal of bone and mineral metabolism, 40, 317-326. doi:10.1007/s00774-021-01287-2. https://pubmed.ncbi.nlm.nih.gov/35059888/
5. Zhu, Linyi, Kamalathevan, Pragash, Koneva, Lada A, Giele, Henk, Shirley, Rebecca. 2022. Variants in ALDH1A2 reveal an anti-inflammatory role for retinoic acid and a new class of disease-modifying drugs in osteoarthritis. In Science translational medicine, 14, eabm4054. doi:10.1126/scitranslmed.abm4054. https://pubmed.ncbi.nlm.nih.gov/36542696/
6. Kataoka, Mayumi, Sahashi, Kentaro, Tsujikawa, Koyo, Iida, Madoka, Katsuno, Masahisa. 2023. Dysregulation of Aldh1a2 underlies motor neuron degeneration in spinal muscular atrophy. In Neuroscience research, 194, 58-65. doi:10.1016/j.neures.2023.04.007. https://pubmed.ncbi.nlm.nih.gov/37146794/
智鼠故事 
